These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28549485)

  • 21. Lessons learnt to keep Europe polio-free: a review of outbreaks in the European Union, European Economic Area, and candidate countries, 1973 to 2013.
    Derrough T; Salekeen A
    Euro Surveill; 2016 Apr; 21(16):. PubMed ID: 27123992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data.
    Pons-Salort M; Molodecky NA; O'Reilly KM; Wadood MZ; Safdar RM; Etsano A; Vaz RG; Jafari H; Grassly NC; Blake IM
    PLoS Med; 2016 Oct; 13(10):e1002140. PubMed ID: 27701425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Poliomyelitis and vaccination strategy in Russian Federation in post-certification period].
    Ivanova OE
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (3):110-4. PubMed ID: 21809654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The final stages of the global eradication of poliomyelitis.
    Grassly NC
    Philos Trans R Soc Lond B Biol Sci; 2013 Aug; 368(1623):20120140. PubMed ID: 23798688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.
    Blake IM; Pons-Salort M; Molodecky NA; Diop OM; Chenoweth P; Bandyopadhyay AS; Zaffran M; Sutter RW; Grassly NC
    N Engl J Med; 2018 Aug; 379(9):834-845. PubMed ID: 30157398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication.
    Ming LC; Hussain Z; Yeoh SF; Koh D; Lee KS
    Global Health; 2020 Jul; 16(1):63. PubMed ID: 32677974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time prediction model of cVDPV2 outbreaks to aid outbreak response vaccination strategies.
    Voorman A; O'Reilly K; Lyons H; Goel AK; Touray K; Okiror S
    Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A105-A112. PubMed ID: 34483024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.
    Shaghaghi M; Soleyman-Jahi S; Abolhassani H; Yazdani R; Azizi G; Rezaei N; Barbouche MR; McKinlay MA; Aghamohammadi A
    Vaccine; 2018 Mar; 36(13):1711-1719. PubMed ID: 29478755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eradication of poliomyelitis in the United States.
    Nathanson N
    Rev Infect Dis; 1982; 4(5):940-50. PubMed ID: 7146731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic evolution of poliovirus: success and difficulties in the eradication of paralytic poliomyelitis].
    Blondel B; Autret A; Brisac C; Pelletier I; Martin-Latil S; Jegouic S; Bessaud M; Joffret ML; Balanant J; Colbère-Garapin F; Delpeyroux F
    Med Trop (Mars); 2008 Apr; 68(2):189-202. PubMed ID: 18630055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
    Famulare M; Selinger C; McCarthy KA; Eckhoff PA; Chabot-Couture G
    PLoS Biol; 2018 Apr; 16(4):e2002468. PubMed ID: 29702638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response.
    Thompson KM; Wallace GS; Tebbens RJ; Smith PJ; Barskey AE; Pallansch MA; Gallagher KM; Alexander JP; Armstrong GL; Cochi SL; Wassilak SG
    Public Health Rep; 2012; 127(1):23-37. PubMed ID: 22298920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication.
    Wassilak SG; Oberste MS; Tangermann RH; Diop OM; Jafari HS; Armstrong GL
    J Infect Dis; 2014 Nov; 210 Suppl 1(0 1):S5-15. PubMed ID: 25316873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WHO regroups efforts against polio resurgence in Africa.
    Ashraf H
    Lancet Infect Dis; 2004 Aug; 4(8):477. PubMed ID: 15298019
    [No Abstract]   [Full Text] [Related]  

  • 35. Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2018-June 2019.
    Jorba J; Diop OM; Iber J; Henderson E; Zhao K; Quddus A; Sutter R; Vertefeuille JF; Wenger J; Wassilak SGF; Pallansch MA; Burns CC
    MMWR Morb Mortal Wkly Rep; 2019 Nov; 68(45):1024-1028. PubMed ID: 31725706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poliomyelitis in selected African and Asian countries.
    Patriarca PA
    Public Health Rev; 1993-1994; 21(1-2):91-8. PubMed ID: 8041892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating vaccine-derived polioviruses: current state of knowledge.
    Kew OM; Wright PF; Agol VI; Delpeyroux F; Shimizu H; Nathanson N; Pallansch MA
    Bull World Health Organ; 2004 Jan; 82(1):16-23. PubMed ID: 15106296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden.
    Platt LR; Estívariz CF; Sutter RW
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S380-9. PubMed ID: 25316859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses.
    Sabin AB
    Eur J Epidemiol; 1991 Mar; 7(2):95-120. PubMed ID: 1646116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.